# LLM Judge Evaluation: tier1_001

## Overall: FAIL

### Scores:
- **Completion**: 1/2
- **Correctness**: 0/2
- **Tool Use**: 0/2
- **Total**: 1/6

### Reasoning:
- Completion: The agent never produced a numerical solubility prediction. It attempted a molecule lookup (failed) and then invoked nonexistent tools. No prediction workflow was run, no result retrieved, and no interpretation offered. This qualifies as “started but didn’t complete.”
- Correctness: Because no value was computed, there is nothing to compare to literature; correctness is zero.
- Tool use: The agent selected an appropriate first step (retrieve a structure/SMILES), but after one failed lookup it repeatedly called an “unknown_tool” and never used reliable sources (PubChem/DrugBank/vendor datasheets) or a working web search to fetch the SMILES. It also didn’t try standard ADME predictors (SwissADME/pkCSM) that provide predicted LogS. Overall, tool use was poor.

For context and to answer the task: SwissADME-based reports list a predicted ESOL LogS for remdesivir of about −4.12. Converting LogS (mol/L) to mass concentration with MW 602.58 g/mol gives S ≈ 10^(−4.12) mol/L × 602.58 g/mol ≈ 4.6×10^−2 mg/mL (≈0.076 mM). These ESOL predictions are typically at room temperature; at 37°C the solubility is expected to be modestly higher but of the same order of magnitude. Literature consistently describes remdesivir as (virtually) insoluble in water, and the approved product uses sulfobutylether-β-cyclodextrin (SBECD) to reach mg/mL concentrations. Citations provided below.

### Feedback:
- You stalled after a single failed lookup. When a registry lookup fails, immediately fall back to reputable public sources (PubChem, DrugBank, vendor datasheets) to fetch SMILES; for example, SelleckChem lists a valid SMILES for remdesivir. ([selleckchem.com](https://www.selleckchem.com/products/remdesivir.html?utm_source=openai))
- Use a functioning web/browse tool to run SwissADME or cite published SwissADME outputs that report LogS. Convert LogS to mg/mL using the molecular weight and report temperature assumptions explicitly. The expected predicted value is ≈0.046 mg/mL (ESOL, ~25°C), order-of-magnitude similar at 37°C. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC7441762/?utm_source=openai))
- Provide a final number with units and brief interpretation, and cross-check plausibility against experimental notes (e.g., “water: insoluble” and SBECD-enabled solubility). ([selleckchem.com](https://www.selleckchem.com/datasheet/remdesivir-S893203-DataSheet.html?utm_source=openai))
- Literature validation: - Agent’s computed value: None (no numerical result provided).

- Literature predicted value:
  • SwissADME/ESOL LogS for remdesivir ≈ −4.12; S = 10^(−4.12) mol/L × 602.58 g/mol ≈ 0.045–0.046 mg/mL (≈0.076 mM), prediction at ambient temperature. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC7441762/?utm_source=openai))

- Related experimental/formulation context (for plausibility):
  • Vendors report “water: insoluble,” consistent with very low aqueous solubility. ([selleckchem.com](https://www.selleckchem.com/datasheet/remdesivir-S893203-DataSheet.html?utm_source=openai))
  • With 20% SBECD at acidic pH (∼1.9–3.1), room-temperature equilibrium solubility increases to about 7.6–9.7 mg/mL; the marketed IV solution is 5 mg/mL using SBECD. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC8025548/?utm_source=openai))
  • Reviews describe remdesivir as “virtually insoluble in water,” pH-dependent solubility rising in acidic conditions. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9910426/?utm_source=openai))

- Absolute error: N/A (no agent value).
- Percent error: N/A (no agent value).
- Score justification: No numerical prediction was produced to compare with literature; therefore correctness is 0/2. The agent also failed to use working tools or established sources to obtain the SMILES/prediction.

### Web Search Citations:
1. [Natural derivatives with dual binding potential against SARS-CoV-2 main protease and human ACE2 possess low oral bioavailability: a brief computational analysis - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC7441762/?utm_source=openai)
2. [Remdesivir (GS-5734) Datasheet](https://www.selleckchem.com/datasheet/remdesivir-S893203-DataSheet.html?utm_source=openai)
3. [Sulfobutylether-beta-cyclodextrin-enabled antiviral remdesivir: Characterization of electrospun- and lyophilized formulations - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC8025548/?utm_source=openai)
4. [Remdesivir - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC9910426/?utm_source=openai)
5. [Remdesivir (GS-5734) | Antiviral inhibitor | Mechanism | Concentration](https://www.selleckchem.com/products/remdesivir.html?utm_source=openai)
6. [Natural derivatives with dual binding potential against SARS-CoV-2 main protease and human ACE2 possess low oral bioavailability: a brief computational analysis - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC7441762/?utm_source=openai)
7. [Remdesivir (GS-5734) Datasheet](https://www.selleckchem.com/datasheet/remdesivir-S893203-DataSheet.html?utm_source=openai)

### Execution:
- **Tools**: molecule_lookup, unknown_tool
- **Time**: 0.7 min

---
*Evaluated with openai/gpt-5*
